ArticleExperimental and therapeutic medicine2019

Astragaloside IV combating liver cirrhosis through the PI3K/Akt/mTOR signaling pathway.

Rendong Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.